Blood tests for fatigue in low-platelet patients
Treatments studied
Part of Blood & lymphatic clinical trials.
This study looks for markers in the blood that are linked to fatigue in people with low platelets. It compares patients who have low platelets from immune or inherited causes to healthy volunteers, to understand why some feel very tired.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have low platelet counts (under 150,000 per microliter) caused by an immune problem or a condition you were born with.
- You have not taken antidepressants (SSRIs or SNRIs), blood thinners, or antiplatelet drugs in the last 10 days.
- You are at least 18 years old (or a child weighing more than 44 pounds).
- You are not under legal guardianship or conservatorship.
- You have social health insurance (like Medicare or Medicaid) and are being seen at one of the participating hospitals.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This study uses a special blood test to create a score that predicts bleeding risk in patients with blood cancers and very low platelet counts. It could help doctors decide if you need extra care to prevent bleeding.
This trial studies whether “TPO” medicines (like eltrombopag or similar drugs) help people age 14 and older with primary immune thrombocytopenia (ITP) who did not respond well to first treatments. It may help raise platelet counts and reduce bleeding, especially when prior therapy hasn’t worked.
This study looks at specific immune blood tests to understand why some people with immune thrombocytopenia (ITP) also develop blood clots. Results may help doctors better assess clot risk in ITP and sort out which antibodies are involved.
This Phase 2 study tests how safe and effective PF-06835375 is for people with primary immune thrombocytopenia (ITP), a condition where platelet counts are too low. It may help reduce bleeding risk by improving platelet levels, depending on the results.
This study looks at healthy adults who donate platelets to understand how platelets change over time. You must fast before blood draws and avoid certain medicines like aspirin or ibuprofen for a week before each visit.
Hear when a new Thrombopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.